Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Thirty years of intracrinology.

The Ochsner journal

Re RN.
PMID: 25598734
Ochsner J. 2014;14(4):673-80.

BACKGROUND: Intracrinology is the study of the intracellular actions, regulation, trafficking, and interactions of extracellular signaling peptides/proteins.METHODS: We describe the development of intracrine biology since the term was defined in 1984.RESULTS: Intracrine biology plays a role in many normal...

Cite
Re RN. Thirty years of intracrinology. Ochsner J. 2014;14(4):673-80
Re, R. N. (2014). Thirty years of intracrinology. The Ochsner journal, 14(4), 673-80.
Re, Richard N. "Thirty years of intracrinology." The Ochsner journal vol. 14,4 (2014): 673-80.
Re RN. Thirty years of intracrinology. Ochsner J. 2014;14(4):673-80. PMID: 25598734; PMCID: PMC4295746.
Copy Download .nbib Format: NLM
Host Intracellular Signaling Events and Pro-inflammatory Cytokine Production in African Trypanosomiasis.

Frontiers in immunology

Kuriakose SM, Singh R, Uzonna JE.
PMID: 27242788
Front Immunol. 2016 May 19;7:181. doi: 10.3389/fimmu.2016.00181. eCollection 2016.

Pathogens, such as bacteria, viruses, and parasites, possess specific molecules or proteins that are recognized by several host innate immune receptors, leading to the activation of several intracellular signaling molecules and pathways. The magnitude and quality of these events...

Cite
Kuriakose SM, Singh R, Uzonna JE. Host Intracellular Signaling Events and Pro-inflammatory Cytokine Production in African Trypanosomiasis. Front Immunol. 2016;7:181doi: 10.3389/fimmu.2016.00181.
Kuriakose, S. M., Singh, R., & Uzonna, J. E. (2016). Host Intracellular Signaling Events and Pro-inflammatory Cytokine Production in African Trypanosomiasis. Frontiers in immunology, 7181. https://doi.org/10.3389/fimmu.2016.00181
Kuriakose, Shiby M, et al. "Host Intracellular Signaling Events and Pro-inflammatory Cytokine Production in African Trypanosomiasis." Frontiers in immunology vol. 7 (2016): 181. doi: https://doi.org/10.3389/fimmu.2016.00181
Kuriakose SM, Singh R, Uzonna JE. Host Intracellular Signaling Events and Pro-inflammatory Cytokine Production in African Trypanosomiasis. Front Immunol. 2016 May 19;7:181. doi: 10.3389/fimmu.2016.00181. eCollection 2016. PMID: 27242788; PMCID: PMC4872169.
Copy Download .nbib Format: NLM
Evolution of breast cancer therapeutics: Breast tumour kinase's role in breast cancer and hope for breast tumour kinase targeted therapy.

World journal of clinical oncology

Hussain HA, Harvey AJ.
PMID: 25114846
World J Clin Oncol. 2014 Aug 10;5(3):299-310. doi: 10.5306/wjco.v5.i3.299.

There have been significant improvements in the detection and treatment of breast cancer in recent decades. However, there is still a need to develop more effective therapeutic techniques that are patient specific with reduced toxicity leading to further increases...

Cite
Hussain HA, Harvey AJ. Evolution of breast cancer therapeutics: Breast tumour kinase's role in breast cancer and hope for breast tumour kinase targeted therapy. World J Clin Oncol. 2014;5(3):299-310doi: 10.5306/wjco.v5.i3.299.
Hussain, H. A., & Harvey, A. J. (2014). Evolution of breast cancer therapeutics: Breast tumour kinase's role in breast cancer and hope for breast tumour kinase targeted therapy. World journal of clinical oncology, 5(3), 299-310. https://doi.org/10.5306/wjco.v5.i3.299
Hussain, Haroon A, and Harvey, Amanda J. "Evolution of breast cancer therapeutics: Breast tumour kinase's role in breast cancer and hope for breast tumour kinase targeted therapy." World journal of clinical oncology vol. 5,3 (2014): 299-310. doi: https://doi.org/10.5306/wjco.v5.i3.299
Hussain HA, Harvey AJ. Evolution of breast cancer therapeutics: Breast tumour kinase's role in breast cancer and hope for breast tumour kinase targeted therapy. World J Clin Oncol. 2014 Aug 10;5(3):299-310. doi: 10.5306/wjco.v5.i3.299. PMID: 25114846; PMCID: PMC4127602.
Copy Download .nbib Format: NLM
Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?.

The Korean journal of pain

Ok HG, Kim SY, Lee SJ, Kim TK, Huh BK, Kim KH.
PMID: 29686804
Korean J Pain. 2018 Apr;31(2):73-79. doi: 10.3344/kjp.2018.31.2.73. Epub 2018 Apr 02.

All drugs have both favorable therapeutic and untoward adverse effects. Conventional opioid analgesics possess both analgesia and adverse reactions, such as nausea, vomiting, and respiratory depression. The opioid ligand binds to µ opioid receptor and non-selectively activates two intracellular...

Cite
Ok HG, Kim SY, Lee SJ, et al. Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?. Korean J Pain. 2018;31(2):73-79doi: 10.3344/kjp.2018.31.2.73.
Ok, H. G., Kim, S. Y., Lee, S. J., Kim, T. K., Huh, B. K., & Kim, K. H. (2018). Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?. The Korean journal of pain, 31(2), 73-79. https://doi.org/10.3344/kjp.2018.31.2.73
Ok, Hwoe Gyeong, et al. "Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?." The Korean journal of pain vol. 31,2 (2018): 73-79. doi: https://doi.org/10.3344/kjp.2018.31.2.73
Ok HG, Kim SY, Lee SJ, Kim TK, Huh BK, Kim KH. Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?. Korean J Pain. 2018 Apr;31(2):73-79. doi: 10.3344/kjp.2018.31.2.73. Epub 2018 Apr 02. PMID: 29686804; PMCID: PMC5904350.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries